In this Book

summary
Children and Drug Safety traces the development, use, and marketing of drugs for children in the twentieth century, a history that sits at the interface of the state, business, health care providers, parents, and children. This book illuminates the historical dimension of a clinical and policy issue with great contemporary significance—many of the drugs administered to children today have never been tested for safety and efficacy in the pediatric population.
 
Each chapter of Children and Drug Safety engages with major turning points in pediatric drug development; themes of children’s risk, rights, protection and the evolving context of childhood; child-rearing; and family life in ways freighted with nuances of race, class, and gender. Cynthia A. Connolly charts the numerous attempts by Congress, the Food and Drug Administration, the American Academy of Pediatrics, and leading pediatric pharmacologists, scientists, clinicians, and parents to address a situation that all found untenable. 

Table of Contents

  1. Cover
  2. restricted access Download |
  1. Title Page, Copyright Page, Dedication Page
  2. pp. i-v
  3. restricted access Download |
  1. Contents
  2. pp. vi-ix
  3. restricted access Download |
  1. Chapter 1: Drug Therapy: From “Baby Killers” to Baby Savers, 1906–1933
  2. pp. 1-15
  3. restricted access Download |
  1. Chapter 2: New Drugs, Old Problems in Pediatrics: From Therapeutic Nihilism to the Antibiotic Era, 1933–1945
  2. pp. 16-32
  3. restricted access Download |
  1. Chapter 3: The Child as Drug Development Problem and Business Opportunity in a New Era, 1945–1961
  2. pp. 33-63
  3. restricted access Download |
  1. Chapter 4: The Growth and Development of the Therapeutic Orphan, 1961–1979
  2. pp. 64-95
  3. restricted access Download |
  1. Chapter 5: A “Big Business Built for Little Customers”: Candy Aspirin, Children, and Poisoning, 1947–1976
  2. pp. 96-123
  3. restricted access Download |
  1. Chapter 6: Children and Psychopharmacology in Postwar America
  2. pp. 124-142
  3. restricted access Download |
  1. Chapter 7: Pediatric Drug Development and Policy after 1979
  2. pp. 143-162
  3. restricted access Download |
  1. Appendix
  2. pp. 163-166
  3. restricted access Download |
  1. Acknowledgments
  2. pp. 167-170
  3. restricted access Download |
  1. Notes
  2. pp. 171-232
  3. restricted access Download |
  1. Index
  2. pp. 233-246
  3. restricted access Download |
  1. About the Author
  2. p. 247
  3. restricted access Download |
  1. Read More in the Series
  2. pp. 248-250
  3. restricted access Download |

Additional Information

ISBN
9780813563893
Related ISBN
9780813563886
MARC Record
OCLC
986523837
Pages
260
Launched on MUSE
2018-04-23
Language
English
Open Access
No
Back To Top

This website uses cookies to ensure you get the best experience on our website. Without cookies your experience may not be seamless.